title: [Carbocysteine in catarrhal ORL diseases].
abstract: By stimulating an enzyme, the sialyltransferase, Carbocisteine has a privileged place in mucomodifying therapeutics. It allows the substitution of pathologic secretions, congesting and aggressive, by physiologic restructured mucus. Tested with success in the E.N.T. catarrhal diseases, Rhinathiol interest is passed in review in each concerned pathologies. About interest of repairing mucociliary transport on the clinical symptomatology improvement.
authors.affiliation: C.H.U. Pellegrin Tripode, Clinique Universitaire ORL, Bordeaux, France.
authors.forename: J P
authors.initials: JP
authors.lastname: Bébéar
authors.forename: V
authors.initials: V
authors.lastname: Calas
authors.forename: B
authors.initials: B
authors.lastname: Lablache Combier
mesh_terms: D002233:Carbocysteine / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D009079:Mucociliary Clearance / Q000187:drug effects; D010038:Otorhinolaryngologic Diseases / Q000188:drug therapy*
chemical_list: D002233:Carbocysteine
vernacular_title: La carbocistéine dans les affections O.R.L catarrhales.